BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25817215)

  • 21. Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury.
    Gonzalez RJ; Lin SA; Bednar B; Connolly B; LaFranco-Scheuch L; Mesfin GM; Philip T; Patel S; Johnson T; Sistare FD; Glaab WE
    Toxicol Pathol; 2017 Jul; 45(5):633-648. PubMed ID: 28830331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases in inflammation.
    Nissinen L; Kähäri VM
    Biochim Biophys Acta; 2014 Aug; 1840(8):2571-80. PubMed ID: 24631662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activatable fluorescent probes: a new concept in optical molecular imaging.
    Lacivita E; Leopoldo M; Berardi F; Colabufo NA; Perrone R
    Curr Med Chem; 2012; 19(28):4731-41. PubMed ID: 22873661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent.
    Schwenck J; Maier FC; Kneilling M; Wiehr S; Fuchs K
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D microscaffolds with triple-marker sensitive nanoprobes for studying fatty liver disease
    Rainu SK; Singh N
    Nanoscale; 2024 May; 16(20):10048-10063. PubMed ID: 38712552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
    Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
    J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Significance of Matrix Metalloproteinases in Oral Diseases.
    Maciejczyk M; Pietrzykowska A; Zalewska A; Knaś M; Daniszewska I
    Adv Clin Exp Med; 2016; 25(2):383-90. PubMed ID: 27627574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous Visualization of Multiple mRNAs and Matrix Metalloproteinases in Living Cells Using a Fluorescence Nanoprobe.
    Pan W; Yang H; Li N; Yang L; Tang B
    Chemistry; 2015 Apr; 21(16):6070-3. PubMed ID: 25752514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential in vivo zymography: a method for observing matrix metalloproteinase activity in the zebrafish embryo.
    Keow JY; Herrmann KM; Crawford BD
    Matrix Biol; 2011 Apr; 30(3):169-77. PubMed ID: 21292002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
    Pohl M; Sakurai H; Bush KT; Nigam SK
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
    Gialeli C; Theocharis AD; Karamanos NK
    FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis.
    Pittayapruek P; Meephansan J; Prapapan O; Komine M; Ohtsuki M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in high-performance fluorescent and bioluminescent RNA imaging probes.
    Xia Y; Zhang R; Wang Z; Tian J; Chen X
    Chem Soc Rev; 2017 May; 46(10):2824-2843. PubMed ID: 28345687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-assembled supramolecular nanoprobes for ratiometric fluorescence measurement of intracellular pH values.
    He L; Yang X; Zhao F; Wang K; Wang Q; Liu J; Huang J; Li W; Yang M
    Anal Chem; 2015 Feb; 87(4):2459-65. PubMed ID: 25610947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luminescent gold nanoparticles: a new class of nanoprobes for biomedical imaging.
    Zhou C; Yang S; Liu J; Yu M; Zheng J
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1199-209. PubMed ID: 24108449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-functional, receptor-targeted fluorogenic probe for in vivo imaging of extracellular protease expressions.
    Zhu L; Xie J; Swierczewska M; Zhang F; Lin X; Fang X; Niu G; Lee S; Chen X
    Bioconjug Chem; 2011 Jun; 22(6):1001-5. PubMed ID: 21574650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
    Waschkau B; Faust A; Schäfers M; Bremer C
    Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.